Among the 6 different types of cancers included in the current study, HCC, PAAD and CRC have relatively sensitive and specific serum tumor antigen markers: AFP for HCC, CA19-9 for PAAD and CRC, and CEA for CRC, respectively. This evidence concerns the gene AFP and pancreatic adenocarcinoma.